NASDAQ

Ligand Pharmaceuticals Incorporated (LGND)

♥ 695 Thanks from members

Live price chart, market sentiment, and community perspectives for Ligand Pharmaceuticals Incorporated (NASDAQ: LGND).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Brookeie S. MassieFounder: David W. GoughLeadership: John Higgins (CEO)Leadership: Matt Demek (CFO)Holder: BlackRock Inc.Holder: The Vanguard GroupHolder: FMR LLCCaptisolRoyalty-based drug financingOmniAb partnerships#LGND#Ligand Pharmaceuticals#Biotech#Captisol#Royalty Aggregator